FY 2018 guidance raised: NCCF (€ per share) expected to grow by over 7%
New 2019-2022 plan: focus on development and growth
- Group NCCF: €167.4 million, €2.26 per share, i.e. +6,6%1
- Portfolio value: €11.4 billion2, i.e. +5.3% vs. December 2017
- EPRA triple net asset value per share at €86.6, +2.1% vs. December 2017, +10.2% yoy
- Commercial Property Investment: EPRA earnings up +6.4%3 to €104.8 million
- Healthcare Property Investment: EPRA earnings up +7.9%3 to €51.1 million
- Property Development: NCCF at €16.2 million (+117%4), ROE5 at 15.6%
- 2018 outlook: guidance revised upward, NCCF (€ per share) up by over 6% compared to 2017 reported NCCF (over 7% compared to 2017 restated)
- 2019–2022 Plan unanimously approved by the Board of Directors
